(Corrects to replace “7.2 percent” with “9.8 percent”, adds link to press release)
Jan 11 (Reuters) - Shire Plc said it will acquire NPS Pharmaceuticals Inc in an all-stock transaction for about $5.2 billion, the companies said in a joint statement on Sunday.
Shire will pay $46.00 per NPS share, representing a premium of about 9.8 percent over NPS’ Friday close.
Dublin-based Shire, whose proposed sale to AbbVie Inc fell apart in October, expects the deal to add to its adjusted earnings from 2016 onward. (Reporting by Natalie Grover in Bengaluru; Editing by Ruth Pitchford)